Secondary Patents: How Pharma Brands Extend Market Exclusivity
Learn how pharmaceutical companies use secondary patents and patent thickets to extend market exclusivity and delay generic competition beyond the primary patent life.
FDA's 180-Day Exclusivity: How First Generic Applicants Gain Market Advantage
FDA's 180-day exclusivity rewards the first generic drug maker to challenge a patent, but delays and deals have turned it into a tool for market control. Here's how it works - and why reform is coming.